(Q38559382)

4 September 2017

1 reference

title

Hybrid volatolomics and disease detection (English)

1 reference

4 September 2017

5

Hossam Haick

0 references

Vera Ruzsanyi

series ordinal

3

object named as

Vera Ruzsanyi

1 reference

4 September 2017

2

Pawel Mochalski

1 reference

4 September 2017

Yoav Y Broza

1

1 reference

PubMed ID

26235374

4 September 2017

Anton Amann

series ordinal

4

1 reference

PubMed ID

26235374

4 September 2017

language of work or name

English

0 references

publication date

31 July 2015

1 reference

Angewandte Chemie International Edition

4 September 2017

0 references

volume

54

1 reference

4 September 2017

11036-11048

1 reference

4 September 2017

38

1 reference

Assessment, origin, and implementation of breath volatile cancer markers

4 September 2017

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201500153

Delay in breast cancer: implications for stage at diagnosis and survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201500153

Impact of delayed diagnosis and treatment in clinically isolated syndrome and multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201500153

A comprehensive review of nongenetic prognostic and predictive factors influencing the heterogeneity of outcomes in advanced non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201500153

Volatile organic compounds of lung cancer and possible biochemical pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201500153

The versatile use of exhaled volatile organic compounds in human health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201500153

The discovery of phenylketonuria: the story of a young couple, two retarded children, and a scientist

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201500153

The scent of disease: volatile organic compounds of the human body related to disease and disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201500153

Combined volatolomics for monitoring of human body chemistry

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201500153

Human exhaled air analytics: biomarkers of diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201500153

Lung cancer biomarkers in exhaled breath

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201500153

Sniffing the unique "odor print" of non-small-cell lung cancer with gold nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201500153

The analysis of volatile organic compounds biomarkers for lung cancer in exhaled breath, tissues and cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201500153

Detection of lung cancer using weighted digital analysis of breath biomarkers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201500153

Diagnostic potential of breath analysis--focus on volatile organic compounds

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201500153

The role of cytochrome P450 in tumour development and progression and its potential in therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201500153

Polymorphic CYP genes and disease predisposition--what have the studies shown so far?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201500153

Aromatase and breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201500153

3-Heptanone as a potential new marker for valproic acid therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201500153

Post-operative elimination of sevoflurane anesthetic and hexafluoroisopropanol metabolite in exhaled breath: pharmacokinetic models for assessing liver function

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201500153

Microbial volatile compounds in health and disease conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201500153

The human volatilome: volatile organic compounds (VOCs) in exhaled breath, skin emanations, urine, feces and saliva.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201500153

Detection of drugs of abuse in exhaled breath using a device for rapid collection: comparison with plasma, urine and self-reporting in 47 drug users

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201500153

Ion mobility spectrometry for pharmacokinetic studies--exemplary application

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201500153

Rapid detection of drugs in biofluids using atmospheric pressure chemi/chemical ionization mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201500153

Determination of amphetamines in human urine by headspace solid-phase microextraction and gas chromatography

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201500153

Hydrocarbon formation in the reductive cleavage of hydroperoxides by cytochrome P-450.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201500153

Reduction of aldehydes and hydrogen cyanide yields in mainstream cigarette smoke using an amine functionalised ion exchange resin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201500153

Production of ethane by rats treated with the colon carcinogen, 1,2-dimethylhydrazine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201500153

Ketone bodies: a review of physiology, pathophysiology and application of monitoring to diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201500153

The role of mathematical modeling in VOC analysis using isoprene as a prototypic example

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201500153

Breath isoprene: muscle dystrophy patients support the concept of a pool of isoprene in the periphery of the human body

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201500153

Unique volatolomic signatures of TP53 and KRAS in lung cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201500153

Volatile fingerprints of cancer specific genetic mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201500153

Non-(13)CO2 targeted breath tests: a feasibility study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201500153

Characterization of volatile organic compounds in human leukocyte antigen heterologous expression systems: a cell's "chemical odor fingerprint".

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201500153

Relation between HLA genes, human skin volatiles and attractiveness of humans to malaria mosquitoes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201500153

A study of the volatile organic compounds exhaled by lung cancer cells in vitro for breath diagnosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201500153

TD-GC-MS analysis of volatile metabolites of human lung cancer and normal cells in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201500153

Release of volatile organic compounds (VOCs) from the lung cancer cell line CALU-1 in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201500153

Analysis of volatile organic compounds (VOCs) in the headspace of NCI-H1666 lung cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201500153

Quantification of acetaldehyde released by lung cancer cells in vitro using selected ion flow tube mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201500153

Quantification of acetaldehyde and carbon dioxide in the headspace of malignant and non-malignant lung cells in vitro by SIFT-MS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201500153

Systematic variation in gene expression patterns in human cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201500153

Multiple oncogenic changes (K-RAS(V12), p53 knockdown, mutant EGFRs, p16 bypass, telomerase) are not sufficient to confer a full malignant phenotype on human bronchial epithelial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201500153

Immortalization of human bronchial epithelial cells in the absence of viral oncoproteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201500153

The molecular basis of lung cancer: molecular abnormalities and therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201500153

Classification of lung cancer histology by gold nanoparticle sensors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201500153

A review of the volatiles from the healthy human body

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201500153

Analysis of exhaled breath for disease detection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201500153

Chemical reporters for biological discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201500153

A review of cancer cachexia and abnormal glucose metabolism in humans with cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201500153

Cancer cell metabolism: implications for therapeutic targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201500153

Detecting active pulmonary tuberculosis with a breath test using nanomaterial-based sensors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201500153

Robust detection of P. aeruginosa and S. aureus acute lung infections by secondary electrospray ionization-mass spectrometry (SESI-MS) breathprinting: from initial infection to clearance

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201500153

Comparative analyses of volatile organic compounds (VOCs) from patients, tumors and transformed cell lines for the validation of lung cancer-derived breath markers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201500153

Quantitative analysis of volatile organic compounds released and consumed by rat L6 skeletal muscle cells in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201500153

Identification of volatile biomarkers of gastric cancer cells and ultrasensitive electrochemical detection based on sensing interface of Au-Ag alloy coated MWCNTs

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201500153

Assessment of the exhalation kinetics of volatile cancer biomarkers based on their physicochemical properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201500153

Modeling soluble gas exchange in the airways and alveoli.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201500153

Assessment of propofol concentrations in human breath and blood by means of HS-SPME-GC-MS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201500153

Endogenous volatile organic compounds in breath and blood of healthy volunteers: examining breath analysis as a surrogate for blood measurements

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201500153

Extra-oral halitosis: an overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201500153

Secondary electrospray ionization-mass spectrometry: breath study on a control group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201500153

A unified algorithm for predicting partition coefficients for PBPK modeling of drugs and environmental chemicals

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201500153

Physiological modeling of isoprene dynamics in exhaled breath

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201500153

A mathematical model for breath gas analysis of volatile organic compounds with special emphasis on acetone

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201500153

Calculating the retention of volatile organic compounds in the lung on the basis of their physicochemical properties.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201500153

Human skin volatiles: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201500153

Analyses of volatile organic compounds from human skin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201500153

The differentiation of the volatile organic signatures of individuals through SPME-GC/MS of characteristic human scent compounds.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201500153

Sweat, the driving force behind normal skin: an emerging perspective on functional biology and regulatory mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201500153

Comparative analysis of volatile metabolomics signals from melanoma and benign skin: a pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201500153

Identification of melanoma with a gas sensor array.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201500153

Volatile biomarkers from human melanoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201500153

Emission rates of selected volatile organic compounds from skin of healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201500153

Monitoring of selected skin-borne volatile markers of entrapped humans by selective reagent ionization time of flight mass spectrometry in NO+ mode

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201500153

A comparative study of the cutaneous microflora of normal feet with low and high levels of odour

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201500153

Analysis of characteristic human female axillary odors: Qualitative comparison to males.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201500153

Comparison of the volatile organic compounds present in human odor using SPME-GC/MS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201500153

Individual and gender fingerprints in human body odour

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201500153

Short chain fatty acids in the human colon

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201500153

Effect of isomalt consumption on faecal microflora and colonic metabolism in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201500153

Alcohol and upper gastrointestinal tract cancer: the role of local acetaldehyde production

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201500153

Gut microbiota-generated metabolites in animal health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201500153

Structure, function and diversity of the healthy human microbiome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201500153

Host-gut microbiota metabolic interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201500153

Saliva specimen: a new laboratory tool for diagnostic and basic investigation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201500153

The diagnostic applications of saliva--a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201500153

Diagnostic potential of saliva: current state and future applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201500153

Biochemical evaluation in human saliva with special reference to ovulation detection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201500153

Analysis of saliva for periodontal diagnosis--a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201500153

Saliva: reflection of the body

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201500153

Analysis of volatile organic compounds in human saliva by a static sorptive extraction method and gas chromatography-mass spectrometry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201500153

Oxidation of toxic and carcinogenic chemicals by human cytochrome P-450 enzymes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201500153

Human extrahepatic cytochromes P450: function in xenobiotic metabolism and tissue-selective chemical toxicity in the respiratory and gastrointestinal tracts

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201500153

Variation in enzymes of arylamine procarcinogen biotransformation among bladder cancer patients and control subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201500153

Blood and breath profiles of volatile organic compounds in patients with end-stage renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201500153

Blood and breath levels of selected volatile organic compounds in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201500153

Gold nanoparticle sensors for detecting chronic kidney disease and disease progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201500153

Small hydrocarbons formed by the peroxidation of squalene

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201500153

Changes in ventilation and its components in normal subjects during sleep

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201500153

Detection of lung, breast, colorectal, and prostate cancers from exhaled breath using a single array of nanosensors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201500153

Noninvasive detection of lung cancer by analysis of exhaled breath

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201500153

Product ion distributions for the reactions of NO(+) with some physiologically significant volatile organosulfur and organoselenium compounds obtained using a selective reagent ionization time-of-flight mass spectrometer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201500153

Non-invasive breath analysis of pulmonary nodules

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201500153

Exhaled methyl nitrate as a noninvasive marker of hyperglycemia in type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201500153

Diabetes and the metabolic syndrome: possibilities of a new breath test in a dolphin model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201500153

Nanomaterial-based sensors for detection of disease by volatile organic compounds

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201500153

Detecting cancer by breath volatile organic compound analysis: a review of array-based sensors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201500153

Exhaled breath analysis with a colorimetric sensor array for the identification and characterization of lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201500153

21 January 2018

Identifiers

DOI

10.1002/ANIE.201500153

1 reference

4 September 2017

1 reference

PubMed ID

26235374